From discovery through development, ProteoGenix utilizes the most advanced technologies to assure an expedited process and assure quality results. These enabling technologies allow high-throughput protein identification—a critical component to effectively utilizing the proteomic map to improve pregnancy management.

ProteoGenix’ enabling technologies include:

• Unique and extensive maternal-fetal specimen banks of biological fluids associated with pregnancy

• Nucleic acid-based molecular technologies specifically optimized to detect and identify critical maternal/fetal/neonatal infectious and pathophysiological diseases

• Proteomic technologies including immunoassay arrays, ELISA test development, liquid chromatography, tandem mass spectrometry

• Bioinformatics – statistical analysis of complex data sets to discover new protein biomarkers and biomarker relationships that can be used to develop proprietary algorithms that link biomarker combinations and concentrations to the diagnosis of maternal, fetal and neonatal disorders

• Proprietary proteomic software and diagnostic algorithms